Inventor · disambiguated record
Daniel R. Deaver
Also filed as: DEAVER DANIEL · DEAVER DANIEL R
49 granted patents·22 pending applications·1,125 citations·filing 1997–2025
99Inventor score
Files withALKERMES PHARMA IRELAND LTD47ALKERMES INC7PENN STATE RES FOUND7ADVANCED INHALATION RES INC3DEAVER DANIEL3
Top patents by PatentIndex Score
71 records- 0199US5985320AMaterials and methods for enhancing cellular internalizationPENN STATE RES FOUND·Filed 1997·Granted Nov 16, 1999·515 cites·33 claims
- 0298US8822488B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2012·Granted Sep 2, 2014·57 cites·21 claims
- 0398USRE42012ECompositions and methods for enhancing receptor-mediated cellular internalizationPENN STATE RES FOUND·Filed 2007·Granted Dec 28, 2010·54 cites·22 claims
- 0497US11351166B2Methods for treating antipsychotic-induced weight gainALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Jun 7, 2022·3 cites·14 claims
- 0597US11241425B2Composition for treating mental illnessALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Feb 8, 2022·3 cites·16 claims
- 0697US10716785B2Methods for treating antipsychotic-induced weight gainALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Jul 21, 2020·8 cites·15 claims
- 0797US9351976B2Pharmaceutical compositions comprising sorbitan estersALKERMES PHARMA IRELAND LTD·Filed 2015·Granted May 31, 2016·22 cites·20 claims
- 0897US9211293B2Opioid agonist antagonist combinationsALKERMES PHARMA IRELAND LTD·Filed 2012·Granted Dec 15, 2015·49 cites·19 claims
- 0997USRE42072ECompositions and methods for enhancing receptor-mediated cellular internalizationPENN STATE RES FOUND·Filed 2007·Granted Jan 25, 2011·51 cites·29 claims
- 1096US11185541B2Methods for treating antipsychotic-induced weight gainALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Nov 30, 2021·3 cites·11 claims
- 1196US9517235B2Methods for treating antipsychotic-induced weight gainALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Dec 13, 2016·13 cites·12 claims
- 1295US11969469B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Apr 30, 2024·2 cites·8 claims
- 1395US10300054B2Methods for treating antipsychotic-induced weight gainALKERMES PHARMA IRELAND LTD·Filed 2018·Granted May 28, 2019·11 cites·20 claims
- 1495US9682936B2Morphan and morphinan analogues, and methods of useALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Jun 20, 2017·14 cites·24 claims
- 1595US9416137B2Morphan and morphinan analogues, and methods of useALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Aug 16, 2016·15 cites·17 claims
- 1694US9943514B2Methods for treating antipsychotic-induced weight gainALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Apr 17, 2018·10 cites·29 claims
- 1794US8778960B2Methods for treating antipsychotic-induced weight gainDEAVER DANIEL·Filed 2011·Granted Jul 15, 2014·29 cites·5 claims
- 1893US9193685B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2013·Granted Nov 24, 2015·17 cites·14 claims
- 1993US9126977B2Methods for treating antipsychotic-induced weight gainALKERMES PHARMA IRELAND LTD·Filed 2014·Granted Sep 8, 2015·13 cites·12 claims
- 2092US10752592B2Morphan and morphinan analogues, and methods of useALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Aug 25, 2020·8 cites·9 claims
- 2192US10736890B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Aug 11, 2020·8 cites·6 claims
- 2292US10287250B2Morphan and morphinan analogues, and methods of useALKERMES PHARMA IRELAND LTD·Filed 2017·Granted May 14, 2019·8 cites·24 claims
- 2392US10231963B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Mar 19, 2019·8 cites·9 claims
- 2492US9861699B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Jan 9, 2018·8 cites·12 claims
- 2592US9656961B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2014·Granted May 23, 2017·14 cites·19 claims
- 2692US6908623B2Compositions and methods for enhancing receptor-mediated cellular internalizationPENN STATE RES FOUND·Filed 2003·Granted Jun 21, 2005·30 cites·16 claims
- 2792US6387390B1Compositions and methods for enhancing receptor-mediated cellular internalizationPENN STATE RES FOUND·Filed 1999·Granted May 14, 2002·65 cites·22 claims
- 2891US11097006B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Aug 24, 2021·2 cites·15 claims
- 2991US9034867B2Pharmaceutical compositions comprising sorbitan estersPERRY JASON M·Filed 2012·Granted May 19, 2015·27 cites·29 claims
- 3090US12194035B2Methods for treating antipsychotic-induced weight gainALKERMES PHARMA IRELAND LTD·Filed 2023·Granted Jan 14, 2025·0 cites·15 claims
- 3190US6652873B2Compositions and methods for enhancing receptor-mediated cellular internalizationPENN STATE RES FOUND·Filed 2002·Granted Nov 25, 2003·23 cites·15 claims
- 3289US12311027B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2024·Granted May 27, 2025·0 cites·15 claims
- 3389US8354534B2Selective opioid compoundsALKERMES INC·Filed 2009·Granted Jan 15, 2013·18 cites·5 claims
- 3488US9498474B2Compositions of buprenorphine and μ AntagonistsALKERMES PHARMA IRELAND LTD·Filed 2014·Granted Nov 22, 2016·6 cites·13 claims
- 3587US2024131024A1Pharmaceutical compositions comprising sorbitan estersALKERMES PHARMA IRELAND LTD·Filed 2023·Application pending·0 cites
- 3686US9918978B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Mar 20, 2018·3 cites·9 claims
- 3786US9913837B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Mar 13, 2018·3 cites·25 claims
- 3885US2024058327A1Pharmaceutical Compositions Comprising Sorbitan EstersALKERMES PHARMA IRELAND LTD·Filed 2023·Application pending·0 cites
- 3984US10314838B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Jun 11, 2019·2 cites·18 claims
- 4084US10226458B2Pharmaceutical compositions comprising sorbitan estersALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Mar 12, 2019·1 cites·21 claims
- 4183US10342877B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Jul 9, 2019·2 cites·23 claims
- 4282US12257249B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2022·Granted Mar 25, 2025·0 cites·15 claims
- 4382US11793805B2Methods for treating antipsychotic-induced weight gainALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Oct 24, 2023·0 cites·9 claims
- 4482US2025312459A1Pharmaceutical Compositions Having Improved Storage StabilityALKERMES PHARMA IRELAND LTD·Filed 2025·Application pending·0 cites
- 4578US10806731B2Compositions of buprenorphine and μ antagonistsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Oct 20, 2020·0 cites·20 claims
- 4677US10639376B2Pharmaceutical compositions having improved storage stabilityALKERMES PHARMA IRELAND LTD·Filed 2019·Granted May 5, 2020·0 cites·19 claims
- 4775US2021196703A1COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONISTSALKERMES PHARMA IRELAND LTD·Filed 2020·Application pending·0 cites
- 4874US2019216805A1Pharmaceutical Compositions Comprising Sorbitan EstersALKERMES PHARMA IRELAND LTD·Filed 2019·Application pending·0 cites
- 4972US11534436B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Dec 27, 2022·0 cites·17 claims
- 5070US10758527B2Opioid agonist antagonist combinationsALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Sep 1, 2020·0 cites·41 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel R. Deaver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →